Scientific Publications 2011 - 2006
| 
| 
2011 - 2006 | 2005 - 2000 | 1999 - 1979
Click on the links below to view the Scientific Publications:
2011
• Valasek C, Cole J, Hensel F, Ye P, Conner MA, Ultee ME. Production and purification of a PER.C6-expressed IgM antibody therapeutic. BioProcess International, 9(11), 28-37 (2011).2010
2009
• Vollmers HP, and Brändlein S. Natural human immunoglobulins in cancer immunotherapy. Immunotherapy, 1, 241-248 (2009).
• Tchoudakova A, Hensel F, Murillo A, Eng B, Foley M, Smith L, Schoenen F, Hildebrand A, Kelter A-R, Ilag LL, Vollmers HP, Brandlein S, McIninch J, Chon J, Lee G and Cacciuttolo M. High level expression of functional human IgMs in human PER.C6® cells. mAbs 1(2): 163-171 (2009).
2008
• Beutner U, Lorenz U, Illert B, Rott L, Timmermann W, Vollmers HP, Muller-Hermelink HK, Thiede A, and Ulrichs K. Neoadjuvant therapy of gastric cancer with the human monoclonal IgM antibody SC-1: Impact on the immune system, Oncol Rep. 19(3), 761-769 (2008).
• Rauschert N, Brändlein S, Holzinger E, Hensel F, Müller-Hermelink HK, Vollmers HP. A new tumor-specific variant of GRP-78 as target for antibody-based therapy, Lab Invest. 88(4), 375-86, (2008).
2007
• Brändlein S, Rauschert N, Rasche L, Dreykluft A, Hensel F, Conzelmann E, Müller-Hermelink HK, Vollmers HP. The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein, Mol Cancer Ther. 6(1), 326-333 (2007).
• Vollmers HP, Brändlein S. Natural antibodies and cancer, J Autoimmun 29(4), 295-302 (2007).
• Vollmers HP, Brändlein S. Tumors: too sweet to remember?, Mol Cancer 6,78 (2007).
2006
• Vollmers HP, Brändlein S. Natural IgM antibodies: from parias to parvenus, Histol Histopathol. 21(12):1355-1366 (2006).
• Vollmers HP, Brändlein S. Natural IgM antibodies: the orphaned molecules in immune surveillance, Adv Drug Deliv Rev. 58(5-6):755-765 (2006).